25.71
-0.3509(-1.35%)
Currency In USD
| Previous Close | 26.06 |
| Open | 25.8 |
| Day High | 28.26 |
| Day Low | 25 |
| 52-Week High | 28.5 |
| 52-Week Low | 3.9 |
| Volume | 3,133 |
| Average Volume | 11,332 |
| Market Cap | 39.51M |
| PE | -31.74 |
| EPS | -0.81 |
| Moving Average 50 Days | 23 |
| Moving Average 200 Days | 15.45 |
| Change | -0.35 |
If you invested $1000 in Precipio, Inc. (PRPO) since IPO date, it would be worth $9.52 as of January 14, 2026 at a share price of $25.709. Whereas If you bought $1000 worth of Precipio, Inc. (PRPO) shares 5 years ago, it would be worth $526.82 as of January 14, 2026 at a share price of $25.709.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
GlobeNewswire Inc.
Dec 05, 2025 3:00 PM GMT
Joint study conducted with Memorial Sloan Kettering Cancer Center demonstrates clear, positive impacts on patient careNEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) will be pre
Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact
GlobeNewswire Inc.
Dec 04, 2025 1:00 PM GMT
NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its secure cloud file environment. The incident was
Precipio Announces its Q3-2025 Financial Results
GlobeNewswire Inc.
Nov 14, 2025 9:30 PM GMT
Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarterNEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The followin